Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2026-03-16

FDA Approved: FLUTICASONE PROPIONATE ALLERGY RELIEF — Original Application (GLENMARK THERAPEUTICS INC., USA)

View source ↗

Summary

FDA approved Glenmark's Fluticasone Propionate Allergy Relief as a new generic nasal spray for allergic rhinitis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FLUTICASONE PROPIONATE ALLERGY RELIEF (FLUTICASONE PROPIONATE)

Snippet

ORIG AP for FLUTICASONE PROPIONATE ALLERGY RELIEF (FLUTICASONE PROPIONATE)